AAAAAA
Results:
1-14
|
Results: 14
Authors:
Egevad, L
Norlen, BJ
Norberg, M
Citation: L. Egevad et al., The value of multiple core biopsies for predicting the Gleason score of prostate cancer, BJU INT, 88(7), 2001, pp. 716-721
Authors:
Alaiya, AA
Oppermann, M
Langridge, J
Roblick, U
Egevad, L
Brandstedt, S
Hellstrom, M
Linder, S
Bergman, T
Jornvall, H
Auer, G
Citation: Aa. Alaiya et al., Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry, CELL MOL L, 58(2), 2001, pp. 307-311
Authors:
Ma, X
Yang, K
Lindblad, P
Egevad, L
Hemminki, K
Citation: X. Ma et al., VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium, ONCOGENE, 20(38), 2001, pp. 5393-5400
Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images
Authors:
Egevad, L
Citation: L. Egevad, Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images, UROLOGY, 57(2), 2001, pp. 291-295
Authors:
Soderstrom, TG
Bjelfman, C
Brekkan, E
Ask, B
Egevad, L
Norlen, BJ
Rane, A
Citation: Tg. Soderstrom et al., Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity, J CLIN END, 86(2), 2001, pp. 855-858
Authors:
Finnstrom, N
Bjelfman, C
Soderstrom, TG
Smith, G
Egevad, L
Norlen, BJ
Wolf, CR
Rane, A
Citation: N. Finnstrom et al., Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR, EUR J CL IN, 31(10), 2001, pp. 880-886
Authors:
Stattin, P
Bylund, A
Rinaldi, S
Biessy, C
Dechaud, H
Stenman, UH
Egevad, L
Riboli, E
Hallmans, G
Kaaks, R
Citation: P. Stattin et al., Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study, J NAT CANC, 92(23), 2000, pp. 1910-1917
Authors:
Lissbrant, IF
Stattin, P
Wikstrom, P
Damber, JE
Egevad, L
Bergh, A
Citation: If. Lissbrant et al., Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival, INT J ONCOL, 17(3), 2000, pp. 445-451
Authors:
Alaiya, A
Roblick, U
Egevad, L
Carlsson, A
Franzen, B
Volz, D
Huwendiek, S
Linder, S
Auer, G
Citation: A. Alaiya et al., Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma, ANAL CELL P, 21(1), 2000, pp. 1-9
Authors:
Yang, K
Lindblad, P
Egevad, L
Hemminki, K
Citation: K. Yang et al., Novel somatic mutations in the VHL gene in Swedish archived sporadic renalcell carcinomas, CANCER LETT, 141(1-2), 1999, pp. 1-8
Authors:
Nilsson, BO
Egevad, L
Jin, MS
Ronquist, G
Busch, C
Citation: Bo. Nilsson et al., Distribution of prostasomes in neoplastic epithelial prostate cells, PROSTATE, 39(1), 1999, pp. 36-40
Authors:
Frimmel, H
Egevad, L
Bengtsson, E
Busch, C
Citation: H. Frimmel et al., Modeling prostate cancer distributions, UROLOGY, 54(6), 1999, pp. 1028-1034
Authors:
Egevad, L
Frimmel, H
Mattson, S
Bengtsson, E
Busch, C
Citation: L. Egevad et al., Biopsy protocol stability in a three-dimensional model of prostate cancer:Changes in cancer yield after adjustment of biopsy positions, UROLOGY, 54(5), 1999, pp. 862-868
Authors:
Egevad, L
Frimmel, H
Norberg, M
Mattson, S
Carlbom, I
Bengtsson, E
Busch, C
Citation: L. Egevad et al., Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: Evaluation of the model by core biopsy simulation, UROLOGY, 53(1), 1999, pp. 192-198
Risultati:
1-14
|